Volume 27, Issue 156 (1-2018)                   J Mazandaran Univ Med Sci 2018, 27(156): 80-88 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zahedifar A, Khodashenas M, Bijari B, Zahedifar F. Effects of Cinnamon on Fasting Blood Sugar and Hemoglobin A1C in Patients with Type II Diabetes Mellitus: A Randomized Clinical Trial . J Mazandaran Univ Med Sci. 2018; 27 (156) :80-88
URL: http://jmums.mazums.ac.ir/article-1-8707-en.html
Abstract:   (1154 Views)

Background and purpose: Diabetes is a chronic disease which requires lifelong use of drugs. These drugs have high costs, therefore, there is a need to find economic, efficient, simple, and local solutions. This study aimed to investigate the effect of oral supplementation of cinnamon on glucose and glycosylated hemoglobin (HbA1c) levels in patients with type II diabetes.
Materials and methods: This clinical trial was conducted in 136 patients with type II diabetes in Birjand, Iran 2015. They were randomly assigned into intervention or placebo groups (n=68 per group). Subjects in the intervention group received 500 mg of cinnamon three times a day after breakfast, lunch, and dinner for 90 days (1500 mg daily). While the other group were advised to take the placebo in the same manner. Fasting blood sugar and HbA1c levels were measured before and after the study.
Results: In this study, the levels of HbA1c reduced significantly in intervention group after the treatment (P≤0.05). Daily intake of 1500 mg of cinnamon for 90 days was found to be effective in reducing glycosylated hemoglobin levels, but it did not have a significant effect on reducing fasting blood sugar in 90 days (P≥0.05).
Conclusion: Daily dose of 1500 mg of cinnamon for 90 days significantly reduced the HbA1C levels in type II diabetic patients and also had a moderate effect on fasting blood sugar concentrations. Therefore, it is recommended alongside conventional medication used in treatment of type II diabetes mellitus.
(Clinical Trials Registry Number: IRCT2016100230098N1)
 
 

Full-Text [PDF 316 kb]   (269 Downloads)    
Type of Study: Research(Original) | Subject: Internal medicine

Add your comments about this article : Your username or Email:
Write the security code in the box

Send email to the article author


© 2018 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb